NR546 Midterm Exam Question and
Answer | Grade A+ | Complete
Verified Guide
• Psychopharmacology . Answer: The study of how medications affect the brain,
behavior, cognition, and emotion through neurotransmitter systems.
• Functional Neuroanatomy . Answer: The relationship between specific brain regions
and their associated cognitive, emotional, and behavioral functions.
• Prefrontal Cortex . Answer: Brain region responsible for executive function, decision-
making, impulse control, planning, and working memory.
• Frontal Lobe Damage . Answer: Associated with impaired judgment, personality
changes, disinhibition, and difficulty with executive functioning.
• Parietal Lobe . Answer: Involved in spatial awareness, sensory integration, and ability
to copy drawings or shapes.
• Inability to Copy a Drawing . Answer: Suggests dysfunction of the parietal lobe.
• Temporal Lobe . Answer: Responsible for memory, auditory processing, and language
comprehension.
• Occipital Lobe . Answer: Primary visual processing center of the brain.
• Limbic System . Answer: Emotional regulation, motivation, memory, and fear
responses (includes amygdala and hippocampus).
• Amygdala . Answer: Central to fear conditioning, emotional responses, and anxiety.
• Hippocampus . Answer: Involved in memory formation and stress regulation; affected
by chronic stress and trauma.
• Autonomy . Answer: Ethical principle recognizing a patient's right to make informed
decisions about their care.
• Informed Consent . Answer: The process of providing adequate information so a
patient can voluntarily agree to treatment.
• Off-Label Prescribing . Answer: Prescribing a medication for an indication not FDA-
approved but supported by clinical evidence.
, • Compliance . Answer: The degree to which a patient follows prescribed treatment
recommendations.
• Medication Adherence . Answer: Active, collaborative participation by the patient in
following the treatment plan.
• Factors Affecting Adherence . Answer: Side effects, complexity of regimen, insight,
stigma, cost, and patient education.
• Genetics . Answer: Study of inherited genetic variations affecting drug response and
disease risk.
• Epigenetics . Answer: Changes in gene expression caused by environmental factors
without altering DNA sequence.
• Epigenetic Influence on Mental Health . Answer: Stress, trauma, and environment can
turn genes 'on' or 'off,' influencing psychiatric illness risk.
• Cytochrome P450 (CYP450) . Answer: Enzyme system responsible for metabolizing
most psychotropic medications.
• Pharmacokinetics . Answer: How the body absorbs, distributes, metabolizes, and
eliminates a drug.
• Pharmacodynamics . Answer: How a drug affects the body and produces its
therapeutic effects.
• Neurotransmission . Answer: The process by which neurons communicate via
chemical messengers.
• Synapse . Answer: The gap between neurons where neurotransmitters are released.
• Retrograde Neurotransmission . Answer: Signaling from the postsynaptic neuron back
to the presynaptic neuron to regulate release.
• Signal Transduction Cascade . Answer: A series of intracellular events that lead to
long-term changes in neuronal function.
• Delayed Antidepressant Response . Answer: Due to downstream gene expression and
receptor adaptations, not immediate neurotransmitter changes.
• Agonist . Answer: A substance that activates a receptor to produce a biological
response.
• Antagonist . Answer: A substance that blocks a receptor, preventing activation.
Answer | Grade A+ | Complete
Verified Guide
• Psychopharmacology . Answer: The study of how medications affect the brain,
behavior, cognition, and emotion through neurotransmitter systems.
• Functional Neuroanatomy . Answer: The relationship between specific brain regions
and their associated cognitive, emotional, and behavioral functions.
• Prefrontal Cortex . Answer: Brain region responsible for executive function, decision-
making, impulse control, planning, and working memory.
• Frontal Lobe Damage . Answer: Associated with impaired judgment, personality
changes, disinhibition, and difficulty with executive functioning.
• Parietal Lobe . Answer: Involved in spatial awareness, sensory integration, and ability
to copy drawings or shapes.
• Inability to Copy a Drawing . Answer: Suggests dysfunction of the parietal lobe.
• Temporal Lobe . Answer: Responsible for memory, auditory processing, and language
comprehension.
• Occipital Lobe . Answer: Primary visual processing center of the brain.
• Limbic System . Answer: Emotional regulation, motivation, memory, and fear
responses (includes amygdala and hippocampus).
• Amygdala . Answer: Central to fear conditioning, emotional responses, and anxiety.
• Hippocampus . Answer: Involved in memory formation and stress regulation; affected
by chronic stress and trauma.
• Autonomy . Answer: Ethical principle recognizing a patient's right to make informed
decisions about their care.
• Informed Consent . Answer: The process of providing adequate information so a
patient can voluntarily agree to treatment.
• Off-Label Prescribing . Answer: Prescribing a medication for an indication not FDA-
approved but supported by clinical evidence.
, • Compliance . Answer: The degree to which a patient follows prescribed treatment
recommendations.
• Medication Adherence . Answer: Active, collaborative participation by the patient in
following the treatment plan.
• Factors Affecting Adherence . Answer: Side effects, complexity of regimen, insight,
stigma, cost, and patient education.
• Genetics . Answer: Study of inherited genetic variations affecting drug response and
disease risk.
• Epigenetics . Answer: Changes in gene expression caused by environmental factors
without altering DNA sequence.
• Epigenetic Influence on Mental Health . Answer: Stress, trauma, and environment can
turn genes 'on' or 'off,' influencing psychiatric illness risk.
• Cytochrome P450 (CYP450) . Answer: Enzyme system responsible for metabolizing
most psychotropic medications.
• Pharmacokinetics . Answer: How the body absorbs, distributes, metabolizes, and
eliminates a drug.
• Pharmacodynamics . Answer: How a drug affects the body and produces its
therapeutic effects.
• Neurotransmission . Answer: The process by which neurons communicate via
chemical messengers.
• Synapse . Answer: The gap between neurons where neurotransmitters are released.
• Retrograde Neurotransmission . Answer: Signaling from the postsynaptic neuron back
to the presynaptic neuron to regulate release.
• Signal Transduction Cascade . Answer: A series of intracellular events that lead to
long-term changes in neuronal function.
• Delayed Antidepressant Response . Answer: Due to downstream gene expression and
receptor adaptations, not immediate neurotransmitter changes.
• Agonist . Answer: A substance that activates a receptor to produce a biological
response.
• Antagonist . Answer: A substance that blocks a receptor, preventing activation.
